Rehabilitation and MRI-based evaluation of the combined therapy of bushenzhichan formula and needle embedding for Parkinson's disease

Abstract

To evaluate the rehabilitation conditions of Parkinson's disease patients using combined therapy of Bushenzhichan formula and needle embedding and to analyze the magnetic resonance imaging test results, 180 Parkinson's disease patients treated at the Beijing Rehabilitation Hospital of Capital Medical University were enrolled as research subjects. They were randomly divided into the control group and the research group, each containing 90 patients. The research group was treated with Madopar as well as the combined therapy of Bushenzhichan formula and needle embedding, while the control group received only Madopar. The rehabilitation conditions of both groups were compared. The total therapeutic efficacy of the research group was higher than that of the control group. By comparing the unified Parkinson's disease rating scale I, scale II and scale III scores, after treatment, the research group showed more significant improvement than the control group. Moreover, magnetic resonance imaging results showed low signal intensity in the red nucleus and substantia nigra. There was no significant difference in the volume of red nucleus and substantia nigra between the two groups. The combined therapy of Bushenzhichan formula and needle embedding can significantly improve the therapeutic efficacy and promote recovery of Parkinson disease patients.